Recurrent Rectal Cancer Clinical Trials in Shanghai, Shanghai Municipality
3 recruitingShanghai, Shanghai Municipality, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
Locally Recurrent Rectal Cancer
Fudan University44 enrolled1 locationNCT07183865
Recruiting
Phase 2
Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
Locally Recurrent Rectal Cancer
Fudan University221 enrolled1 locationNCT06928584
Recruiting
Phase 2
The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
Recurrent Rectal Cancer
Fudan University93 enrolled1 locationNCT05628038